PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
Aug 11, 2016 – Oct 2, 2026, Dividends reinvested
- Final balance
- $119,709
- CAGR
- +27.74%
- Max drawdown
- −85.79%
- Sharpe ratio
- 0.71
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Annualized from 3Y- 1M
- −4.12%
- 3M
- +6.41%
- 6M
- +34.96%
- YTD
- +60.36%
- 1Y
- +115.54%
- 3Y
- +104.65%
- 5Y
- +50.82%
- 10Y
- +20.82%
- Since 2016
- +27.74%
Metrics
Since 2016| Volatility | 89.66% |
|---|---|
| Sortino ratio | 1.19 |
| Calmar ratio | 0.32 |
| Best year, 2020 | +185.96% |
| Worst year, 2022 | −68.10% |
| Positive years | 6 of 9 |
| Longest drawdown | 4.2 years |
Worst drawdowns
Since 2016| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −85.8% | Sep 2021 | Jun 2022 | Mar 2025 | 3.5 years |
| −82.1% | Dec 2016 | Dec 2019 | Feb 2021 | 4.2 years |
| −31.6% | Mar 2025 | Apr 2025 | Aug 2025 | 6 months |
| −20.3% | Oct 2016 | Nov 2016 | Nov 2016 | 3 weeks |
| −19.0% | Mar 2021 | Mar 2021 | May 2021 | 2 months |
Annual returns
2016 from Aug 11 · 2026 through Oct 2